Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic Surgical Patients (HEROS)
Sarcopenia, Frailty
About this trial
This is an interventional treatment trial for Sarcopenia focused on measuring Nutrition, Prehabilitation, Surgery, Rehabilitation, Exercise, HMB
Eligibility Criteria
Inclusion Criteria:
- between 40-90 years old
- are sarcopenia (defined by the Asian Workgroup of Sarcopenia 2019 definition)
- due to undergo elective major gastrointestinal surgery
- able to satisfy at least 2 weeks of prehabilitation before surgery
- ambulant
- able to comply with physiotherapy and dietician advice
Exclusion Criteria:
- Are pregnant
- Are prisoners
- Intellectually, mentally or emotionally deemed not able to provide an informed consent and/or are unable to fill up the post-procedure questionnaires
- Have disease conditions requiring emergent/semi-emergent operation
- Diabetes on oral hyperglycemic agents (OHGA)
- Chronic Kidney Disease (CKD) or End-stage Renal Failure (ESRF)
- Unable to or decline assessment for sarcopenia
Sites / Locations
- Sengkang General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Sarcopenic patients
Healthy individuals
Ensure Plus Advance + resistance training (Prehab) Rehabilitation 2months post surgery
To make meaningful comparison of muscle quality, 10 healthy non-sarcopenic individuals from the same age range would also be recruited and will undergo muscle quality assessment using MuscleSound® once upon recruitment so that an objective comparison for IMAT can be made with our sarcopenic study cohort. This is to aid the study team to identify "normal" IMAT vs an IMAT for sarcopenic individuals. Any improvement of our cohort's muscle quality can be benchmarked against healthy muscle quality so that more meaningful comparison can be made. This control group would not be undergoing surgery, nor will they have any ONS supplied.